Suchergebnisse - "*Ritonavir"

PubPharm (9)

1

Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy : a case report

enthalten in: BMC infectious diseases | 2020

von Otto, S. | George, P. | Mercedes, R. | +1

2

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression : a retrospective study from the clinical practice

enthalten in: BMC infectious diseases | 2019

von Borghetti, A. | Lombardi, F. | Gagliardini, R. | +10

3

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

enthalten in: BMC infectious diseases | 2019

von Borghetti, A. | Lombardi, F. | Gagliardini, R. | +10

4

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

enthalten in: BMC infectious diseases | 2019

von Borghetti, A. | Lombardi, F. | Gagliardini, R. | +10

5

Early antiretroviral treatment (eART) limits viral diversity over time in a long-term HIV viral suppressed perinatally infected child

enthalten in: BMC infectious diseases | 2016

von Palma, P. | Zangari, P. | Alteri, C. | +7

6

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT) : 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +10

7

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +9

8

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

enthalten in: BMC infectious diseases | 2013

von Kumar, P. | DeJesus, E. | Huhn, G. | +9

9

Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding : the PROMISE-PEP trial Protocol ANRS 12174

enthalten in: BMC infectious diseases | 2012

von Nagot, N. | Kankasa, C. | Meda, N. | +9

1
[1]